This inventor holds 3 USPTO granted patents. Top assignee: Hoechst Aktiengesellschaft. Active years: 1980-1982.
Company Filing History:
Years Active: 1980-1982
Title: The Innovations of Volker Oeding
Introduction
Volker Oeding is a notable inventor based in Kelkheim, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of enzyme inhibitors. With a total of 3 patents to his name, Oeding's work has implications for various applications in health and nutrition.
Latest Patents
Oeding's latest patents include an innovative .alpha.-Amylase inhibitor derived from a streptomycete. This inhibitor targets glycoside hydrolases of the digestive tract, specifically pancreatic .alpha.-amylase. The invention involves the fermentation of the specific microorganism Streptomyces tendae, strain 4158, along with its variants and mutants. The patent also covers processes for the isolation and purification of the inhibitor, showcasing Oeding's expertise in microbiology and enzymology.
Career Highlights
Throughout his career, Volker Oeding has been associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical and chemical sectors. His work has contributed to advancements in enzyme research and its applications in various industries. Oeding's innovative approach has positioned him as a key figure in his field.
Collaborations
Oeding has collaborated with notable colleagues such as Werner Pfaff and Laszlo Vertesy. These partnerships have likely enhanced the scope and impact of his research, fostering a collaborative environment for innovation.
Conclusion
Volker Oeding's contributions to the field of biochemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in enzyme inhibitors and their applications in health and nutrition.